Breast Cancer Stage I
Oncology·MeSH: Neoplasm, Residual
Prevalence
287.0 / 100K
Incidence
128.0 / 100K/yr
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| chemotherapy | GH Research PLC (GHRS) |
Frequently asked questions
How many drugs are in development for Breast Cancer Stage I?
BioSniper tracks 1 drug in development for Breast Cancer Stage I across 1 company.
How many clinical trials target Breast Cancer Stage I?
There are 2 clinical trials targeting Breast Cancer Stage I tracked by BioSniper.
What is the prevalence of Breast Cancer Stage I?
The estimated prevalence of Breast Cancer Stage I is approximately 287.0 per 100,000 population.
Deep-dive into Breast Cancer Stage I
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis